These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26131172)

  • 1. MDM2 SNP309 variation confers the susceptibility to hepatocellular cancer: a meta-analysis based on 4271 subjects.
    Lv J; Zhu B; Zhang L; Xie Q; Zhuo W
    Int J Clin Exp Med; 2015; 8(4):5822-30. PubMed ID: 26131172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of MDM2 SNP309 variation with lung cancer risk: evidence from 7196 cases and 8456 controls.
    Zhuo W; Zhang L; Zhu B; Ling J; Chen Z
    PLoS One; 2012; 7(7):e41546. PubMed ID: 22844496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects.
    Zhuo W; Zhang L; Ling J; Zhu B; Chen Z
    Leuk Lymphoma; 2012 Nov; 53(11):2245-52. PubMed ID: 22563815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 SNP309 variation increases cervical cancer risk among Asians.
    Zhuo X; Ren J; Li D; Wu Y; Zhou Q
    Tumour Biol; 2014 Jun; 35(6):5331-7. PubMed ID: 24532430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis.
    Ding H; Dai Y; Ning Z; Fan N; Wang Z; Li P; Zhang L; Tao Y; Wang H
    Medicine (Baltimore); 2016 Mar; 95(12):e2941. PubMed ID: 27015167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals.
    Zhuo X; Ye H; Li Q; Xiang Z; Zhang X
    Medicine (Baltimore); 2016 Mar; 95(9):e2948. PubMed ID: 26945408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between murine double minute 2 T309G polymorphism and risk of liver cancer.
    Tang T; Song X; Yang Z; Huang L; Wang W; Tan H
    Tumour Biol; 2014 Nov; 35(11):11353-7. PubMed ID: 25119589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of MDM2 T309G polymorphism in susceptibility and prognosis of nonsmall cell lung cancer: a meta-analysis.
    Kong Q; Li P; Tian Q; Ha MW
    Genet Test Mol Biomarkers; 2014 May; 18(5):357-65. PubMed ID: 24673452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers.
    Chen B; Cao L; Hu KW; Zhang JW; Meng XL; Xiong MM
    Tumour Biol; 2014 Apr; 35(4):3431-8. PubMed ID: 24338709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MDM2 promoter T309G polymorphism with oral cancer risk: A meta-analysis of 3,536 subjects.
    Yang XI; Zhu Y; Ye D; Liu Y; Sun H; Ruan M; Liu W
    Mol Clin Oncol; 2016 Jul; 5(1):175-180. PubMed ID: 27330794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 SNP309T>G polymorphism with hepatocellular carcinoma risk: a meta-analysis.
    Liu GY; Jiang DK; Shen SQ; Yu L
    Arch Med Res; 2011 Feb; 42(2):149-55. PubMed ID: 21565629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between MDM2 T309G single nucleotide polymorphism and esophageal cancer susceptibility: An updated meta-analysis.
    Yin L; Shen G; Zhu B
    Thorac Cancer; 2020 Mar; 11(3):672-678. PubMed ID: 31970867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of the MDM2 T309G polymorphism and gastric cancer risk.
    Song B; Duan ZY; Zhong YH; Lei N; Yang YQ; Luo KY
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6649-51. PubMed ID: 24377582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of associations between the MDM2-T309G polymorphism and prostate cancer risk.
    Chen T; Yi SH; Liu XY; Liu ZG
    Asian Pac J Cancer Prev; 2012; 13(9):4327-30. PubMed ID: 23167337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
    Xue Z; Zhu X; Teng Y
    Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.
    Yan YL; Han F; Tan WM; Wu CP; Qin X
    Asian Pac J Cancer Prev; 2014; 15(16):6767-72. PubMed ID: 25169523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases.
    Hu S; Zhao L; Yang J; Hu M
    Meta Gene; 2013 Dec; 1():126-37. PubMed ID: 25606382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
    Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
    Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of associations between MDM2 SNP309 polymorphism and gastric cancer risk.
    Chen W; Wu Q; Ren H
    Biomed Rep; 2014 Jan; 2(1):105-111. PubMed ID: 24649079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.